Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents. 2014

Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
Department of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok 10110, Thailand. Electronic address: ratchanok@swu.ac.th.

A new series of chalcone-coumarin derivatives (9-19) linked by the 1,2,3-triazole ring were synthesized through the azide/alkyne dipolar cycloaddition. Hybrid molecules were evaluated for their cytotoxic activity against four cancer cell lines (e.g., HuCCA-1, HepG2, A549 and MOLT-3) and antimalarial activity toward Plasmodium falciparum. Most of the synthesized hybrids, except for analogs 10 and 16, displayed cytotoxicity against MOLT-3 cell line without affecting normal cells. Analogs (10, 11, 16 and 18) exhibited higher inhibitory efficacy than the control drug, etoposide, in HepG2 cells. Significantly, the high cytotoxic potency of the hybrid 11 was shown to be non-toxic to normal cells. Interestingly, the chalcone-coumarin 18 was the most potent antimalarial compound affording IC50 value of 1.60 μM. Molecular docking suggested that the cytotoxicity of reported hybrids could be possibly due to their dual inhibition of α- and β-tubulins at GTP and colchicine binding sites, respectively. Furthermore, falcipain-2 was identified to be a plausible target site of the hybrids given their antimalarial potency.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin

Related Publications

Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
December 2010, Bioorganic & medicinal chemistry letters,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
January 2020, Bioorganic chemistry,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
October 2021, Molecules (Basel, Switzerland),
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
September 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
March 2023, Chemico-biological interactions,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
January 2019, Anti-cancer agents in medicinal chemistry,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
September 2011, European journal of medicinal chemistry,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
September 2019, Chemical biology & drug design,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
September 2022, Archiv der Pharmazie,
Ratchanok Pingaew, and Amporn Saekee, and Prasit Mandi, and Chanin Nantasenamat, and Supaluk Prachayasittikul, and Somsak Ruchirawat, and Virapong Prachayasittikul
January 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!